Erasca, Inc. (ERAS)
NASDAQ: ERAS · Real-Time Price · USD
2.270
+0.030 (1.34%)
At close: Nov 7, 2025, 4:00 PM EST
2.250
-0.020 (-0.88%)
After-hours: Nov 7, 2025, 7:58 PM EST
Erasca Market Cap
Erasca has a market cap or net worth of $643.93 million as of November 7, 2025. Its market cap has decreased by -11.61% in one year.
Market Cap
643.93M
Enterprise Value
306.61M
1-Year Change
-11.61%
Ranking
Category
Stock Price
$2.27
Market Cap Chart
Since the IPO on July 16, 2021, Erasca's market cap has decreased from $1.86B to $643.93M, a decrease of -65.35%. That is a compound annual growth rate of -21.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 643.93M | -9.26% |
| Dec 31, 2024 | 709.65M | 121.27% |
| Dec 29, 2023 | 320.72M | -50.41% |
| Dec 30, 2022 | 646.73M | -65.76% |
| Dec 31, 2021 | 1.89B | 1.66% |
| Jul 16, 2021 | 1.86B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 839.37B |
| Johnson & Johnson | 450.47B |
| AbbVie | 387.13B |
| UnitedHealth Group | 291.28B |
| AstraZeneca | 260.82B |
| Novartis AG | 242.27B |
| Abbott Laboratories | 217.27B |
| Merck & Co. | 212.91B |